Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Mitochondrial dysfunction in Parkinson's disease.

J T Greenamyre¹, G MacKenzie, T I Peng

¹Department of Neurology, Emory University, Atlanta, GA 30322, USA.

Biochemical Society Symposium

|September 16, 2000

Summary

This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

A Small Device May Deliver King-Sized Solutions for Patients With an Exacerbation of Cystic Fibrosis.

International journal of pediatrics·2024

Same author

Diagnostic accuracy of diffusion-weighted imaging in variant Creutzfeldt-Jakob disease.

Neuroradiology·2023

Same author

Beyond the hashtag: describing and understanding the full impact of the #BJSConnect tweet chat May 2019.

BJS open·2021

Same author

80 years on.

British dental journal·2020

Same author

How scientists and physicians use Twitter during a medical congress.

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases·2019

Same author

LRRK2 G2019S-induced mitochondrial DNA damage is LRRK2 kinase dependent and inhibition restores mtDNA integrity in Parkinson's disease.

Human molecular genetics·2017

Same journal

The cell biology of inositol lipids and phosphates. Proceedings of the 2006 Biochemical Society Annual Symposium. Birmingham, United Kingdom. March 29-30, 2006.

Biochemical Society symposium·2007

Same journal

Trafficking of phosphatidylinositol by phosphatidylinositol transfer proteins.

Biochemical Society symposium·2007

Same journal

Regulation of phospholipase D activity, membrane targeting and intracellular trafficking by phosphoinositides.

Biochemical Society symposium·2007

Same journal

Evolution of the diverse biological roles of inositols.

Biochemical Society symposium·2007

Same journal

Understanding the biological significance of diphosphoinositol polyphosphates ('inositol pyrophosphates').

Biochemical Society symposium·2007

Same journal

Multiple functions of inositolphosphorylceramides in the formation and intracellular transport of glycosylphosphatidylinositol-anchored proteins in yeast.

Biochemical Society symposium·2007

See all related articles

A novel rotenone infusion model replicates Parkinson's disease (PD) neurodegeneration, revealing how mitochondrial dysfunction and NMDA receptor activation create a harmful cycle. This discovery offers new insights into PD pathogenesis.

Area of Science:

Neuroscience
Mitochondrial Biology
Neurodegenerative Diseases

Background:

Parkinson's disease (PD) pathogenesis is linked to Complex I dysfunction in mitochondria.
Existing PD models do not fully replicate the slow neurodegeneration observed in patients.

Purpose of the Study:

To develop and validate a novel animal model of Parkinson's disease (PD).
To investigate the role of mitochondrial dysfunction and excitotoxicity in PD pathogenesis.

Main Methods:

Chronic systemic infusion of rotenone, a Complex I inhibitor, in a novel PD model.
Observation of selective dopaminergic nerve terminal loss and substantia nigra neuron degeneration over months.
Analysis of metabolic impairment, ATP depletion, and cellular calcium homeostasis disruption.

Related Experiment Videos

Main Results:

The rotenone model successfully replicated the distribution of dopaminergic pathology seen in PD.
The model demonstrated a slow neurodegeneration time course, mimicking idiopathic PD.
Identified a feed-forward cycle where mitochondrial dysfunction exacerbates NMDA receptor activity, leading to further mitochondrial damage.

Conclusions:

The novel rotenone infusion model provides a more accurate representation of PD neurodegeneration.
Mitochondrial impairment and NMDA receptor overactivation form a critical cycle in PD pathogenesis.
NMDA receptor antagonists may hold potential as a neuroprotective strategy for Parkinson's disease.